These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group. Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650 [TBL] [Abstract][Full Text] [Related]
3. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Levine EG; Bloomfield CD Semin Oncol; 1992 Feb; 19(1):47-84. PubMed ID: 1736370 [TBL] [Abstract][Full Text] [Related]
4. Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation. Del Cañizo Mf; Amigo Mf; Hernández JM; Sanz G; Núñez R; Carreras E; Alegre A; Cuesta B; Mataix R Haematologica; 2000 Apr; 85(4):403-9. PubMed ID: 10756367 [TBL] [Abstract][Full Text] [Related]
5. The incidence of secondary leukemias. Leone G; Mele L; Pulsoni A; Equitani F; Pagano L Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043 [TBL] [Abstract][Full Text] [Related]
7. [Therapy-related acute leukaemia and myelodysplastic syndrome]. Díaz Beveridge R; Aparicio Urtasun J An Med Interna; 2003 May; 20(5):257-68. PubMed ID: 12831302 [TBL] [Abstract][Full Text] [Related]
8. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation. Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528 [TBL] [Abstract][Full Text] [Related]
9. Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma. Howe R; Micallef IN; Inwards DJ; Ansell SM; Dewald GW; Dispenzieri A; Gastineau DA; Gertz MA; Geyer SM; Hanson CA; Lacy MQ; Tefferi A; Litzow MR Bone Marrow Transplant; 2003 Aug; 32(3):317-24. PubMed ID: 12858205 [TBL] [Abstract][Full Text] [Related]
10. Biology and therapy of secondary leukaemias. Dann EJ; Rowe JM Best Pract Res Clin Haematol; 2001 Mar; 14(1):119-37. PubMed ID: 11355927 [TBL] [Abstract][Full Text] [Related]
11. Treatment of therapy-related leukemia and myelodysplastic syndrome. Kantarjian HM; Estey EH; Keating MJ Hematol Oncol Clin North Am; 1993 Feb; 7(1):81-107. PubMed ID: 7680643 [TBL] [Abstract][Full Text] [Related]
12. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277 [TBL] [Abstract][Full Text] [Related]
13. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460 [TBL] [Abstract][Full Text] [Related]
14. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome. Kröger N; Brand R; van Biezen A; Cahn JY; Slavin S; Blaise D; Sierra J; Zander A; Niederwieser D; de Witte T; Bone Marrow Transplant; 2006 Jan; 37(2):183-9. PubMed ID: 16299545 [TBL] [Abstract][Full Text] [Related]
15. Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes. Ballen KK; Antin JH Hematol Oncol Clin North Am; 1993 Apr; 7(2):477-93. PubMed ID: 8468276 [TBL] [Abstract][Full Text] [Related]